Laguna Hills-based Vessix Vascular, a developer of catheter technology, said this week that it has raised $23M in a Series B financing round. The round was led by Edmond de Rothschild Investment Partners (EdRIP), and also included Orbimed Advisors, CDF Dinova Venture Partners, NeoMed Management, and Christopher Weil & Company. Raphael Wisniewski of EdRip and Vince Burgess of OrbiMed join the company's board as part of the funding. Vessix develops novel percutaneous radiofrequency (RF) balloon catheter technology, used for treating vascular conditions. Vessix Vascular was previously known as Minnow Medical. More information »